Kenya will begin the national rollout of Lenacapavir, a long-acting HIV prevention injection, on Thursday, February 26, 2026, as part of efforts to cut new infections to zero by 2030. Eligibility and Precautions Health experts have clarified that not everyone at risk of contracting HIV will qualify for the jab.…
Kenya has received an initial shipment of 21,000 starter doses of Lenacapavir, a long-acting injectable HIV pre-exposure prophylaxis (PrEP), marking a significant milestone in the country’s fight against new infections. Landmark Step in HIV Prevention The consignment was received by Director General for Health Dr. Patrick Amoth, who described Kenya’s…